Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards

Life Health > Long-Term Care Planning

Genworth Might Resume Long-Term Care Insurance Sales by July

Your article was successfully shared with the contacts you provided.

What You Need to Know

  • The effects of the COVID-19 pandemic continue to help stand-alone LTCI operating earnings.
  • Genworth is starting by working to increase long-term care support services sales.
  • The company would issue new, relatively low-risk LTCI products with help from a reinsurance partner.

Genworth Financial is working with a reinsurer to begin selling a new individual long-term care insurance (LTCI) policy that could reach the market as early as July 1, 2022.

Tom McInerney did not name the company that would be sharing the LTCI product risk. He described it as a “highly rated reinsurance partner.” The product would be a relatively low-risk, predictable LTCI) policy, he said.

“We are still in the early stages of engaging with rating agencies and other stakeholders” McInerney said.

Before Genworth could begin selling the new LTCI policy, it would have to get permission from state regulators to adjust the premiums every year, he added.

“We firmly believe that the ability to re-rate LTC policies annually is absolutely critical to the success of future LTC insurance products,” McInerney said.

McInerney talked about Genworth’s possible return to the LTCI market today, during a conference call the Richmond, Virginia-based company held to go over its results for the third quarter with securities analysts.

The third quarter ended Sept. 30.

Genworth last sold significant amounts of new LTCI coverage in early 2016.

The History

Genworth was one of the pioneers in the U.S. private LTCI market, and it has paid LTCI claims for about 330,000 insureds.

LTCI issuers depend heavily on investing premium dollars in bonds to generate much of the cash used to pay benefits.

When the LTCI market came to life, many consumer advocates and regulators argued that the products should be designed in such a way that the premiums for in-force policies could not increase, because many of the policyholders would be retirees, who might be trying to get by on a fixed income. States imposed tough rate stability rules on LTCI products.

Genworth and many competitors have had trouble with creating adequate LTCI reserves because of low interest rates on bonds, problems with the policyholder behavior assumptions used to price older policies, and difficulties with getting permission from the regulators in some states to increase LTCI premiums.

Some consumer groups and regulators still question why a big, commercial company should be able to change a deal it made with customers simply because it guessed wrong about the future. McInerney has argued that it’s in the interest of states and most policyholders to allow enough premium increases to keep the LTCI issuers solvent.

LTCI’s Future

McInerney has reported on Genworth’s website that he himself now shares responsibility for care for his 87-year-old mother, who has severe rheumatoid arthritis.

The need for long-term care planning is there, but issuers of stand-alone LTCI have suffered from low product penetration, and most of insurers’ current offerings involve attempts to innovate on the edges, with products that combine LTC benefits with life insurance policies or annuities, McInerney said.

“We believe the market is ripe for innovation, and that Genworth, with our 40-plus years of LTC experience and expertise is uniquely prepared to capitalize on this opportunity,” McInerney said. “As we’ve said before, we believe a successful reinvigoration of the U.S. LTC market will address both financing and services and ultimately, will help to reduce the likelihood of people needing care and/or less than the cost of care that they need.”

Although Genworth will try to resume selling stand-alone LTCI, it will focus more on providing advice and other low-capital activities, such as selling LTCI policies designed in such a way that a reinsurer shares most of the risk, McInerney said.

One early step, he said, will be to try to expand Genworth’s CareScout subsidiary, which brings in fee revenue by providing care support services for individuals, health care organizations and other insurers.

The Earnings

Genworth held the conference call to go over earnings for the third quarter, which ended Sept. 30.

Genworth reported $318 million in net income for the third quarter on $2.1 billion in revenue, compared with $436 million in net income on $2.3 billion in revenue for the third quarter of 2020.

Results look different partly because of the effects of an initial public offering of some of Genworth’s stake in Enact Holdings, Genworth’s mortgage insurance subsidiary. The IPO reduced Genworth’s ownership of Enact to 81.6%, from 100%.

The LTCI business produced $133 million in adjusted operating income for the third quarter on $1.3 billion in revenue, up from $59 million in adjusted operating income on $1.5 billion in revenue for the earlier quarter.

The gross benefits ratio, or ratio of benefits and other changes in policy reserves to net earned premiums, fell to 123%, from 136%, due in part to the effects of premium increases.

Genworth has been requesting LTCI rate increases that should help the LTCI business break even, and the company received state insurance regulator approvals for increases that could generate about $117 million in additional revenue.

Early on, most LTCI policyholders kept their policies in force in the face of premium increases and simply paid the higher premiums.

But, over time, many LTCI policyholders have accepted some form of benefits reduction, Genworth says.

Overall, about 15% of the policyholders affected by rate actions have dropped their policies, 28% have used reduced benefits options to hold down premium increases, and 57% have continued to pay the full, increased premiums, Genworth says.

Executives also talked about the impact of the COVID-19 pandemic.

The pandemic is hurting life insurance results, because life insurance benefits costs are increasing, but the pandemic is helping LTCI results, by reducing the likelihood that insureds will use their benefits, and by increasing the mortality rate for insureds who have been using their LTCI benefits to pay for care.

At this point, Genworth is setting reserves aside to prepare for the possibility that policyholders could begin using more care and that the insureds who have survived the pandemic so far may have a longer life expectancy than the pool of insureds the company before the pandemic started, executives said.

The death rate for Genworth’s LTCI benefits users was about 13% above average in the first quarter, about 10% below average in the second quarter, and about 8.3% above average in the third quarter. according to an earnings call slide deck.

Pictured: Tom McInerney (Photo: Victor J. Blue/Bloomberg)


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.